Search Non-Antibody Products
|
|
|
|
|
Non-antibody Products (Kits, Proteins, Microbial Antigens, Tissues, Services, etc.) - Page 1 of 5,777
| Name |
Description |
Size |
Catalog # |
Supplier |
|
| AS 101 |
Minimum Purity: > 98%. Immunomodulator; inhibits IL-10 synthesis and potentiates IL-1alpha, IL-2 and TNF-alpha release. |
50mg |
2446 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 101 |
Minimum Purity: > 98%. Immunomodulator; inhibits IL-10 synthesis and potentiates IL-1alpha, IL-2 and TNF-alpha release. |
10mg |
2446 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 101 |
Minimum Purity: > 98%. R-(-)-enantiomer of gossypol (Cat. No. 1964). Mimics the BH3 domains of Bcl-2, Bcl-XL and Mcl-1. Disrupts heterodimerization of Bcl-2 with proapoptotic family members. Induces apoptosis in vitro through activation of caspase... |
50mg |
3367 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 101 |
Minimum Purity: > 98%. R-(-)-enantiomer of gossypol (Cat. No. 1964). Mimics the BH3 domains of Bcl-2, Bcl-XL and Mcl-1. Disrupts heterodimerization of Bcl-2 with proapoptotic family members. Induces apoptosis in vitro through activation of caspase... |
10mg |
3367 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 101 |
n/a |
10 mg |
2446/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 101 |
n/a |
50 mg |
2446/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 101 |
n/a |
10 mg |
3367/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 101 |
n/a |
50 mg |
3367/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 1120 |
Minimum Purity: > 99%. High affinity retinol-binding protein 4 (RBP4) ligand (Ki = 8.3 nM); non-retinoid. Selective against a range of different cellular targets. As efficacious as fenretinide (Cat. No. 1396) in the reduction of serum RBP4 and ret... |
50mg |
3793 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 1120 |
Minimum Purity: > 99%. High affinity retinol-binding protein 4 (RBP4) ligand (Ki = 8.3 nM); non-retinoid. Selective against a range of different cellular targets. As efficacious as fenretinide (Cat. No. 1396) in the reduction of serum RBP4 and ret... |
10mg |
3793 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 1120 |
n/a |
10 mg |
3793/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 1120 |
n/a |
50 mg |
3793/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1269574 |
Minimum Purity: > 98%. GPR119 receptor agonist (EC50 = 2.5 µM in HEK293 cells expressing human GPR119). Enhances insulin secretion stimulated by glucose in vivo. Orally available. |
50mg |
4177 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1269574 |
Minimum Purity: > 98%. GPR119 receptor agonist (EC50 = 2.5 µM in HEK293 cells expressing human GPR119). Enhances insulin secretion stimulated by glucose in vivo. Orally available. |
10mg |
4177 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1269574 |
GPR119 Receptor Agonist |
10 mg |
4177/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1269574 |
GPR119 Receptor Agonist |
50 mg |
4177/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 19 |
Minimum Purity: > 98%. Potent 5-HT7 receptor agonist (IC50 = 0.83 nM). Enhances memory consolidation and reverses scopolamine- or dizocilpine-induced amnesia in vivo. |
10mg |
1968 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 19 |
Minimum Purity: > 98%. Potent 5-HT7 receptor agonist (IC50 = 0.83 nM). Enhances memory consolidation and reverses scopolamine- or dizocilpine-induced amnesia in vivo. |
50mg |
1968 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 19 |
5-HT7 Receptor Agonist |
10 mg |
1968/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 19 |
5-HT7 Receptor Agonist |
50 mg |
1968/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1949490 |
Minimum Purity: > 99%. Selective SHIP2 (SH2 domain-containing inositol 5'-phosphatase 2) inhibitor (IC50 values are 0.34 µM and 0.62 µM for mouse and human respectively); displays approximately 30-fold affinity for SHIP2 over SHIP1. In... |
10mg |
3718 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1949490 |
Minimum Purity: > 99%. Selective SHIP2 (SH2 domain-containing inositol 5'-phosphatase 2) inhibitor (IC50 values are 0.34 µM and 0.62 µM for mouse and human respectively); displays approximately 30-fold affinity for SHIP2 over SHIP1. In... |
50mg |
3718 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 1949490 |
Inositol Phosphatase Inhibitor |
10 mg |
3718/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 1949490 |
Inositol Phosphatase Inhibitor |
50 mg |
3718/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 205804 |
Minimum Purity: > 98%. Selective inhibitor of E-selectin and ICAM-1 expression (IC50 values are 20, 25 and > 1000 nM for TNF-alpha-induced E-selectin, ICAM-1 and VCAM-1 expression respectively). Effective inhibitor of cell-cell adhesion in an in v... |
10mg |
2524 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 205804 |
Minimum Purity: > 98%. Selective inhibitor of E-selectin and ICAM-1 expression (IC50 values are 20, 25 and > 1000 nM for TNF-alpha-induced E-selectin, ICAM-1 and VCAM-1 expression respectively). Effective inhibitor of cell-cell adhesion in an in v... |
50mg |
2524 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 205804 |
Cell Adhesion Inhibitor |
10 mg |
2524/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 205804 |
Cell Adhesion Inhibitor |
50 mg |
2524/50 |
 R&D SYSTEMS, INC. |
More Info
|
| S 24795 |
Minimum Purity: > 98%. Partial agonist of alpha7 nAChR. Improves mnemonic function in aged mice for the treatment of aging-related memory disturbances. Displays more efficient memory-enhancing effects than memantine (Cat.No 0773) in Alzheimer's di... |
50mg |
3518 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 24795 |
Minimum Purity: > 98%. Partial agonist of alpha7 nAChR. Improves mnemonic function in aged mice for the treatment of aging-related memory disturbances. Displays more efficient memory-enhancing effects than memantine (Cat.No 0773) in Alzheimer's di... |
10mg |
3518 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 24795 |
Nicotinic (a7) Receptor Agonist |
10 mg |
3518/10 |
 R&D SYSTEMS, INC. |
More Info
|
| S 24795 |
Nicotinic (a7) Receptor Agonist |
50 mg |
3518/50 |
 R&D SYSTEMS, INC. |
More Info
|
| AS 252424 |
Minimum Purity: > 98%. Potent and selective inhibitor of PI 3-kinase gamma (IC50 values are 33 and 935 nM for PI3Kgamma and PI3Kalpha respectively). |
10mg |
3671 |
 TOCRIS BIOSCIENCE |
More Info
|
| AS 252424 |
PI 3-Kinase Inhibitor |
10 mg |
3671/10 |
 R&D SYSTEMS, INC. |
More Info
|
| S 25585 |
Minimum Purity: > 98%. Potent neuropeptide Y (NPY) Y5 receptor antagonist (IC50 values are 5.4, > 1000, > 10 000 and > 10 000 nM at Y5, Y1, Y2 and Y4 receptors respectively) that displays no affinity for a wide range of other receptors. Does not p... |
10mg |
3432 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 25585 |
Minimum Purity: > 98%. Potent neuropeptide Y (NPY) Y5 receptor antagonist (IC50 values are 5.4, > 1000, > 10 000 and > 10 000 nM at Y5, Y1, Y2 and Y4 receptors respectively) that displays no affinity for a wide range of other receptors. Does not p... |
50mg |
3432 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 25585 |
NPY Receptor Antagonist |
10 mg |
3432/10 |
 R&D SYSTEMS, INC. |
More Info
|
| S 25585 |
NPY Receptor Antagonist |
50 mg |
3432/50 |
 R&D SYSTEMS, INC. |
More Info
|
| A 286982 |
Minimum Purity: > 99%. Potent inhibitor of the LFA-1/ICAM-1 interaction (IC50 values are 44 and 35 nM in LFA-1/ICAM-1 binding and LFA-1-mediated cell adhesion assays respectively). |
10mg |
4228 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 286982 |
Minimum Purity: > 99%. Potent inhibitor of the LFA-1/ICAM-1 interaction (IC50 values are 44 and 35 nM in LFA-1/ICAM-1 binding and LFA-1-mediated cell adhesion assays respectively). |
50mg |
4228 |
 TOCRIS BIOSCIENCE |
More Info
|
| A 286982 |
Integrin Receptor Inhibitor |
10 mg |
4228/10 |
 R&D SYSTEMS, INC. |
More Info
|
| A 286982 |
Integrin Receptor Inhibitor |
50 mg |
4228/50 |
 R&D SYSTEMS, INC. |
More Info
|
| 293 |
n/a |
n/a |
n/a |
 NIH AIDS RESEARCH & REFERENCE REAGENT PROGRAM |
More Info
|
| 293 |
n/a |
n/a |
n/a |
VIRCELL S.L. |
More Info
|
| S 32826 |
Minimum Purity: > 98%. Inhibitor of autotaxin (IC50 = 9 nM). Displays similar inhibitory effects at all three autotaxin isoforms (alpha, beta and gamma). Exhibits no affinity for lysophosphatidic acid receptor 1 (LPA1) at concentrations up to 10 &... |
10mg |
3404 |
 TOCRIS BIOSCIENCE |
More Info
|
| S 32826 |
Autotaxin Inhibitor |
10 mg |
3404/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 56 |
Minimum Purity: > 99%. Orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 µM, IC50 = 95 µM). Inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2alpha production. |
10mg |
3531 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 56 |
Minimum Purity: > 99%. Orally active inhibitor of lipocalin-type prostaglandin D synthase (L-PGDS) (Ki = 75 µM, IC50 = 95 µM). Inhibits the production of PGD2 from PGH2 in vitro, with no effect on PGE2 or PGF2alpha production. |
50mg |
3531 |
 TOCRIS BIOSCIENCE |
More Info
|
| AT 56 |
Synthase/Synthetase Inhibitor |
10 mg |
3531/10 |
 R&D SYSTEMS, INC. |
More Info
|
| AT 56 |
Synthase/Synthetase Inhibitor |
50 mg |
3531/50 |
 R&D SYSTEMS, INC. |
More Info
|
Search Non-Antibody Products
|